Share on StockTwits

Smith & Nephew plc (NYSE:SNN) saw a large increase in short interest in June. As of June 13th, there was short interest totalling 769,246 shares, an increase of 52.2% from the May 30th total of 505,437 shares, AnalystRatingsNetwork reports. Based on an average daily trading volume, of 551,834 shares, the short-interest ratio is presently 1.4 days. Approximately 0.0% of the shares of the stock are short sold.

A number of research firms have recently commented on SNN. Analysts at Numis Securities Ltd reiterated a “hold” rating on shares of Smith & Nephew plc in a research note on Tuesday. Separately, analysts at Goldman Sachs reiterated a “neutral” rating on shares of Smith & Nephew plc in a research note on Tuesday, June 24th. Finally, analysts at Galvan Research reiterated a “buy” rating on shares of Smith & Nephew plc in a research note on Wednesday, June 11th. Seven investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company has an average rating of “Buy” and an average price target of $97.00.

Shares of Smith & Nephew plc (NYSE:SNN) opened at 88.14 on Thursday. Smith & Nephew plc has a 1-year low of $57.33 and a 1-year high of $100.90. The stock has a 50-day moving average of $88.44 and a 200-day moving average of $78.90. The company has a market cap of $15.742 billion and a price-to-earnings ratio of 28.04.

Smith & Nephew plc (NYSE:SNN) last released its earnings data on Thursday, May 1st. The company reported $0.89 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.93 by $0.04. Analysts expect that Smith & Nephew plc will post $4.13 EPS for the current fiscal year.

Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (NYSE:SNN) and advanced wound management.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.